Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Russian Mining Chemical Company, operating under the brand Brucite+, is a leading producer of magnesium-based products derived from the Kuldur brucite deposit. The company specializes in the mining and processing of magnesium hydroxide (brucite) to create high-purity materials for the pharmaceutical, food, and industrial sectors. In the healthcare industry, RMCC provides pharmaceutical-grade magnesium hydroxide and magnesium oxide used as active pharmaceutical ingredients (APIs) and excipients in antacids, laxatives, and mineral supplements. The company manages the entire production chain from extraction to fine chemical milling, ensuring compliance with international quality standards. RMCC serves a global market, providing essential mineral components for digestive health and nutritional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Russian Mining Chemical Company.